/ /

  • linkedin
  • Increase Font
  • Sharebar

    Letters to the editor: NBEO's board certification, EHR products

    Profession violation?

    I agree wholeheartedly with Dr. Timothy J. Smith's letter strongly condemning NBEO's board certification (“Plea for NBEO,” May 2014). Perhaps this enterprise is motivated by our continuing inferiority complex regarding ophthalmology. But while we try to become more “medical,” more non-optometrists perform refractions in ophthalmology offices. Shouldn't we be more concerned about this violation of our profession?

    Alfred Jan, OD, MA

    San Jose, CA

     

    Another EHR solution

    Thank you for your article “EHR Roundup” in the June issue of Optometry Times. This article brought up some good points about the future of EHR implementation by optometrists and gave a good overview of a few of the EHR products in the eyecare market.

    I wanted to add one other software, QuikEyes, to your list. QuikEyes was developed in 2006 to provide an affordable, easy-to-use EHR option for small to medium-sized private and corporate-affiliated optometry practices. QuikEyes is cloud-based and includes an optometry-specific EHR module, practice management (with inventory) module and a fully embedded patient communications (text/e-mail) module. The software is designed to allow OD users to purchase only the specific modules needed for their practice. 

    QuikEyes is a complete ambulatory certified EHR for Stage 1 Meaningful Use and is currently awaiting Stage 2 certification from InfoGard. 

    Matt Lowenstein OD

    Founder, President, QuikEyes, Inc.

    Overland Park, KS

     

    In “EHR roundup” in our June issue, pricing was not included for MaximEyes. The information that should have been listed is: Starts at $375 per month (includes customer support)

    Optometry Times regrets the omission.

     

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available